These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of insulin resistance in obese women with and without acanthosis nigricans. Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659 [TBL] [Abstract][Full Text] [Related]
3. Significance of acanthosis nigricans in childhood obesity. Guran T; Turan S; Akcay T; Bereket A J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925 [TBL] [Abstract][Full Text] [Related]
4. Is acanthosis nigricans a marker of insulin resistance in obese children? Hirschler V; Aranda C; Oneto A; Gonzalez C; Jadzinsky M Diabetes Care; 2002 Dec; 25(12):2353. PubMed ID: 12453987 [No Abstract] [Full Text] [Related]
5. Acanthosis nigricans and insulin sensitivity in patients with achondroplasia and hypochodroplasia due to FGFR3 mutations. Alatzoglou KS; Hindmarsh PC; Brain C; Torpiano J; Dattani MT J Clin Endocrinol Metab; 2009 Oct; 94(10):3959-63. PubMed ID: 19622626 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with acanthosis nigricans in obese adolescents. Galhardo J; Hunt LP; Shield JP Diabet Med; 2012 Jul; 29(7):e117-20. PubMed ID: 22288782 [TBL] [Abstract][Full Text] [Related]
7. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents. Slyper AH; Kashmer L; Huang WM; Re'em Y J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1107-11. PubMed ID: 25010776 [TBL] [Abstract][Full Text] [Related]
8. Acanthosis nigricans and insulin resistance. Plourde PV; Marks JG; Hammond JM J Am Acad Dermatol; 1984 May; 10(5 Pt 2):887-91. PubMed ID: 6373859 [TBL] [Abstract][Full Text] [Related]
9. Acanthosis nigricans: a marker for hyperinsulinemia. Brockow K; Steinkraus V; Rinninger F; Abeck D; Ring J Pediatr Dermatol; 1995 Dec; 12(4):323-6. PubMed ID: 8747578 [TBL] [Abstract][Full Text] [Related]
10. [Acanthosis nigricans in pregnancy]. Galasso F; Sbano E; Altamura V; Della Corte G G Ital Dermatol Venereol; 1989; 124(11-12):511-5. PubMed ID: 2700559 [TBL] [Abstract][Full Text] [Related]
11. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans. Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980 [TBL] [Abstract][Full Text] [Related]
12. Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study. Bellot-Rojas P; Posadas-Sanchez R; Caracas-Portilla N; Zamora-Gonzalez J; Cardoso-Saldaña G; Jurado-Santacruz F; Posadas-Romero C J Drugs Dermatol; 2006 Oct; 5(9):884-9. PubMed ID: 17039655 [TBL] [Abstract][Full Text] [Related]
14. [Effect of chronic blockade of the opiodergic receptor on insulin resistance in a hyperandrogenic woman]. Sir T; López G; Alba F; Cipriano A; Candía M; Castillo T; Devoto L Rev Med Chil; 1994 Apr; 122(4):441-7. PubMed ID: 7809540 [TBL] [Abstract][Full Text] [Related]
15. Peripheral muscle glucose and potassium transport in a family with acanthosis nigricans and insulin resistance. Saad MJ; Foss MC Braz J Med Biol Res; 1989; 22(6):683-6. PubMed ID: 2695195 [TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in obese adolescents. Li HJ; Huang CY; Lee HC; Chen MR; Lo FS; Lin CH; Wang AM; Shih BF; Lee YJ Acta Paediatr Taiwan; 2005; 46(2):61-6. PubMed ID: 16302580 [TBL] [Abstract][Full Text] [Related]
17. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children. Copeland K; Pankratz K; Cathey V; Immohotichey P; Maddox J; Felton B; McIntosh R; Parker D; Burgin C; Blackett P J Okla State Med Assoc; 2006 Jan; 99(1):19-24. PubMed ID: 16499154 [TBL] [Abstract][Full Text] [Related]